| 摘要 |
The present invention relates to a composition intended to treat inflammation in a subject by administration within an exudate of said subject, the composition comprising a composition less than or equal to 125 mM of one or more salts of active ingredients making it possible to treat one or more symptoms of that inflammation, preferably less than or equal to 100 mM, and particularly preferably less than or equal to 75 mM. |
